AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 60 filers reported holding AURA BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $652,325 | -27.4% | 72,723 | 0.0% | 0.00% | – |
Q2 2023 | $898,129 | +52.6% | 72,723 | +14.7% | 0.00% | – |
Q1 2023 | $588,473 | +17.2% | 63,413 | +32.6% | 0.00% | – |
Q4 2022 | $501,974 | -41.1% | 47,807 | +1.7% | 0.00% | – |
Q3 2022 | $852,000 | +39.7% | 47,003 | +9.3% | 0.00% | – |
Q2 2022 | $610,000 | +79.9% | 43,009 | +179.7% | 0.00% | – |
Q1 2022 | $339,000 | +68.7% | 15,379 | +30.1% | 0.00% | – |
Q4 2021 | $201,000 | – | 11,822 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $51,617,000 | 12.92% |
Matrix Capital Management Company, LP | 4,112,870 | $69,837,000 | 0.78% |
Rock Springs Capital Management LP | 1,008,114 | $17,118,000 | 0.40% |
Nantahala Capital Management | 99,146 | $1,683,000 | 0.06% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,255,480 | $21,318,000 | 0.04% |
Citadel Advisors | 2,315,102 | $37,318,000 | 0.01% |
CAAS CAPITAL MANAGEMENT LP | 10,000 | $170,000 | 0.00% |
Concord Wealth Partners | 150 | $3,000 | 0.00% |
Allianz Asset Management GmbH | 55,145 | $936,000 | 0.00% |
FMR LLC | 471,300 | $8,003,000 | 0.00% |